Advertisement

Topics

PubMed Journals Articles About "Cardiac Patients With Cardiac Resynchronization Therapy" RSS

06:39 EDT 25th June 2019 | BioPortfolio

Cardiac Patients With Cardiac Resynchronization Therapy PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Cardiac Patients With Cardiac Resynchronization Therapy articles that have been published worldwide.

More Information about "Cardiac Patients With Cardiac Resynchronization Therapy" on BioPortfolio

We have published hundreds of Cardiac Patients With Cardiac Resynchronization Therapy news stories on BioPortfolio along with dozens of Cardiac Patients With Cardiac Resynchronization Therapy Clinical Trials and PubMed Articles about Cardiac Patients With Cardiac Resynchronization Therapy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cardiac Patients With Cardiac Resynchronization Therapy Companies in our database. You can also find out about relevant Cardiac Patients With Cardiac Resynchronization Therapy Drugs and Medications on this site too.

Showing "Cardiac Patients With Cardiac Resynchronization Therapy" PubMed Articles 1–25 of 43,000+

Cardiac magnetic resonance in patients with cardiac resynchronization therapy: is it time to scan with resynchronization on?

Cardiac resynchronization therapy (CRT) is recommended in international guidelines for patients with heart failure due to important left ventricular systolic dysfunction (or heart failure with reduced ejection fraction) and ventricular conduction tissue disease. Cardiac magnetic resonance (CMR) represents the most powerful imaging tool for dynamic assessment of the volumes and function of cardiac chambers but is rarely utilized in patients with CRT due to limitations on the device, programming and scanning....


Cardiac Resynchronization Therapy Using Pacemakers versus Defibrillators in Patients with Non-Ischemic Cardiomyopathy: The United States Experience from 2007 to 2014.

The impact of implantable defibrillator therapy on outcomes of patients with non-ischemic cardiomyopathy (NICM) who receive a cardiac resynchronization therapy (CRT) device is controversial.

Can cardiac resynchronization therapy be used as a tool to reduce sudden cardiac arrest risk?

Patients with cardiomyopathy and reduced left ventricular (LV) ejection fraction are at risk of heart failure (HF) symptoms and sudden cardiac arrest (SCA). In selected HF patients, cardiac resynchronization therapy (CRT) provides LV reverse remodeling and improves the cellular and molecular function. However controversial results have been published regarding the effect of CRT on the residual ventricular arrhythmia risk. Indeed, the decrease in SCA risk is inconsistent and some factors strongly influence t...


Survival after cardiac resynchronization therapy: results from 50 084 implantations.

Randomized controlled trials have shown that cardiac resynchronization therapy (CRT) prolongs survival in patients with heart failure. No studies have explored survival after CRT in relation to individuals in the general population (relative survival, RS). We sought to determine observed and RS after CRT in a nationwide cohort undergoing CRT.

Linking cross-bridge cycling kinetics to response to cardiac resynchronization therapy: a multiscale modelling study.

Cardiac resynchronization therapy (CRT) is currently the most widely used treatment for heart failure patients with left bundle branch block (LBBB). In recent years, the presence of septal rebound stretch (SRS) has been found to be a positive indicator for CRT response although the mechanism is unknown.

Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure.

Evidence regarding the incremental benefit of cardiac resynchronization therapy (CRT) with a defibrillator (CRT-D) versus without (CRT-P) in elderly patients with heart failure is limited. We compared mortality and cardiac hospitalisation between CRT-D and CRT-P in the elderly.

Predicting defibrillator benefit in patients with cardiac resynchronization therapy: a competing risk study.

Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in selected heart failure patients but decision-making regarding selection of CRT-defibrillator or CRT-pacemaker is an ongoing debate.

Utilization of cardiac resynchronization therapy in patients with heart failure in the Northern Region of New Zealand.

Cardiac resynchronization therapy (CRT) has been shown to improve morbidity and mortality for heart failure (HF) patients. Little is known about the trends in CRT use and outcomes of these patients in New Zealand.

Myocardial constructive work and cardiac mortality in resynchronization therapy candidates.

Recent studies have shown that myocardial constructive work (CW) assessed by pressure-strain loops (PSLs) is an independent predictor of a volumetric response to cardiac resynchronization therapy (CRT). The aim of this study was to evaluate the role of CW in predicting the cardiac outcome of heart failure patients undergoing CRT.

Mid-term feasibility and safety of downgrade procedure from defibrillator to pacemaker with cardiac resynchronization therapy.

Some patients who undergo implantation of cardiac resynchronization therapy with defibrillator (CRT-D) survive long enough, thus requiring CRT-D battery replacement. Defibrillator therapy might become unnecessary in patients who have had significant clinical improvement and recovery of left ventricular ejection fraction (LVEF) after CRT-D implantation.

Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality.

Transvenous lead extraction (TLE) may be necessary due to system infection/erosion or lead malfunction. Cardiac resynchronization therapy (CRT) patients undergoing TLE may be at greater risk due to increased comorbidities. We examined whether patients with CRT systems undergoing TLE had more comorbidities and higher 30-day mortality than those with non-CRT devices.

Cardiac resynchronization therapy with His bundle pacing.

A novel therapy offering cardiac resynchronization therapy (CRT) with additional lead placed in His bundle has been reported in a few case reports and case series as improving haemodynamical and clinical condition of patients with permanent AF in whom other therapeutic methods have not been successful.

Development of a Biomarker Panel to Predict Cardiac Resynchronization Therapy Response: Results from the SMART-AV Trial.

Predicting a favorable cardiac resynchronization therapy (CRT) response holds great clinical importance.

Left Ventricular End-Systolic Volume Can Predict 1-Year Hierarchical Clinical Composite End Point in Patients with Cardiac Resynchronization Therapy.

This study aimed to elucidate which echocardiographic criteria at three time points, for cardiac resynchronization therapy (CRT) response, are accurate in discriminating the hierarchical clinical composite end point (HCCEP).

Cardiac resynchronization therapy: need to synchronize patients and device longevities with comorbidities.

Lead extraction in patients with cardiac resynchronization therapy devices: are they worse than the others?

Etiologic impact on difference on clinical outcomes of patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis.

To compare long-term clinical outcomes between patients with heart failure due to non-ischemic cardiomyopathy (NICM) and those due to ischemic cardiomyopathy (ICM) after cardiac resynchronization therapy (CRT).

Association Left Ventricular Lead and Ventricular Arrhythmias after Upgrade to Cardiac Resynchronization Therapy in Patients with Implantable Cardioverter Defibrillators.

There are some controversial reports related to the pro-arrhythmic or anti-arrhythmic potential of cardiac resynchronization therapy (CRT) and little is known about the relationship between ventricular arrhythmia (VA) and left ventricular (LV)-lead threshold.

Electrical remodelling post cardiac resynchronization therapy in patients with ischemic and non-ischemic heart failure.

The beneficial effects of cardiac resynchronization therapy (CRT) in heart failure are largely considered to be due to improved mechanical contractility. The contributory role of electrical remodelling is less clear. We sought to evaluate the impact of electrical remodelling in these patients.

Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial.

In the IN-TIME trial, automatic daily implant-based multiparameter telemonitoring significantly improved clinical outcomes in patients with chronic systolic heart failure and implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D). We compared IN-TIME results for ICD and CRT-D subgroups.

Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals.

Cardiac resynchronization therapy (CRT) provides significant reduction in morbidity and mortality in select patients with left ventricular systolic dysfunction and specific parameters of electrocardiographic evidence of dyssynchrony. Relative to the 2012 American College of Cardiology/American Heart Association/Heart Rhythm Society guideline update for patient selection, little is known about the contemporary use of CRT in the United States.

Long Term Outcomes in Patients with Chronic Right Ventricular Pacing Upgraded to Cardiac Resynchronization therapy.

In patients with chronic systolic heart failure and frequent right ventricular pacing (RVP), upgrade to cardiac resynchronization therapy (CRT) has become a common practice despite a lack of randomized clinical trials. We aimed to evaluate long term outcomes in patients upgraded to CRT from chronic RVP compared to de novo CRT implants.

Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter-defibrillator therapy: comment.

Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter-defibrillator therapy: comment-Authors' reply.

Twelve-Lead ECG Optimization of Cardiac Resynchronization Therapy in Patients With and Without Delayed Enhancement on Cardiac Magnetic Resonance Imaging.

Background Delayed enhancement ( DE ) on magnetic resonance imaging is associated with ventricular arrhythmias, adverse events, and worse left ventricular mechanics. We investigated the impact of DE on cardiac resynchronization therapy ( CRT ) outcomes and the effect of CRT optimization. Methods and Results We studied 130 patients with ejection fraction ( EF ) ≤40% and QRS ≥120 ms, contrast cardiac magnetic resonance imaging, and both pre- and 1-year post- CRT echocardiograms. Sixty-three (48%) patient...


Advertisement
Quick Search
Advertisement
Advertisement